The ASC reportedly is the first in the region to use the technology, which treats kidney stones and benign enlarged prostates.
Many urologists at the center had requested the technology, the release said, citing its versatility, speed, accuracy and efficiency.
The freestanding, multispecialty ASC conducts more than 22,000 procedures a year.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.